Literature DB >> 25332947

Statins - the Holy Grail for cancer?

Preet Paul Singh1, Siddharth Singh1.   

Abstract

Entities:  

Year:  2013        PMID: 25332947      PMCID: PMC4200692          DOI: 10.3978/j.issn.2305-5839.2012.12.02

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  19 in total

1.  Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.

Authors:  Stefanos Bonovas; Kalitsa Filioussi; Nikolaos Tsavaris; Nikolaos M Sitaras
Journal:  J Clin Oncol       Date:  2006-09-25       Impact factor: 44.544

2.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 3.  Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Preet Paul Singh; Abha Goyal Singh; Mohammad Hassan Murad; William Sanchez
Journal:  Gastroenterology       Date:  2012-10-12       Impact factor: 22.682

4.  Daily aspirin use and cancer mortality in a large US cohort.

Authors:  Eric J Jacobs; Christina C Newton; Susan M Gapstur; Michael J Thun
Journal:  J Natl Cancer Inst       Date:  2012-08-10       Impact factor: 13.506

5.  The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

Authors:  I Ben Sahra; K Laurent; A Loubat; S Giorgetti-Peraldi; P Colosetti; P Auberger; J F Tanti; Y Le Marchand-Brustel; F Bost
Journal:  Oncogene       Date:  2008-01-21       Impact factor: 9.867

6.  Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Authors:  Peter M Rothwell; Michelle Wilson; Jacqueline F Price; Jill F F Belch; Tom W Meade; Ziyah Mehta
Journal:  Lancet       Date:  2012-03-21       Impact factor: 79.321

7.  Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival.

Authors:  Craig J Currie; Chris D Poole; Sara Jenkins-Jones; Edwin A M Gale; Jeffrey A Johnson; Christopher Ll Morgan
Journal:  Diabetes Care       Date:  2012-01-20       Impact factor: 19.112

8.  The differential effects of statins on the metastatic behaviour of prostate cancer.

Authors:  M Brown; C Hart; T Tawadros; V Ramani; V Sangar; M Lau; N Clarke
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

9.  Statin use and risk of prostate cancer: a meta-analysis of observational studies.

Authors:  Dipika Bansal; Krishna Undela; Sanjay D'Cruz; Fabrizio Schifano
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

10.  Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.

Authors:  Jonathan R Emberson; Patricia M Kearney; Lisa Blackwell; Connie Newman; Christina Reith; Neeraj Bhala; Lisa Holland; Richard Peto; Anthony Keech; Rory Collins; John Simes; Colin Baigent
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

View more
  3 in total

1.  Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design.

Authors:  Tatiana Y Hargrove; Laura Friggeri; Zdzislaw Wawrzak; Suneethi Sivakumaran; Eugenia M Yazlovitskaya; Scott W Hiebert; F Peter Guengerich; Michael R Waterman; Galina I Lepesheva
Journal:  J Lipid Res       Date:  2016-06-16       Impact factor: 5.922

Review 2.  Chemoprevention of cancer: current evidence and future prospects.

Authors:  Vassiliki Benetou; Areti Lagiou; Pagona Lagiou
Journal:  F1000Res       Date:  2015-09-28

Review 3.  Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis.

Authors:  Raseen Tariq; Dhruvika Mukhija; Arjun Gupta; Siddharth Singh; Darrell S Pardi; Sahil Khanna
Journal:  Infect Drug Resist       Date:  2018-03-13       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.